(ANSA) - ROME, APRIL 14 - The EMA makes it known in a note that "it is investigating all reported cases" regarding the Johnson & Johnson vaccine "and will decide if regulatory action is necessary. The agency is working closely together with the US F and other international regulators. EMA is accelerating this assessment and currently plans to issue a recommendation next week. " While the review is underway, the EU authority "remains of the opinion that the benefits of the vaccine in preventing Covid-19 outweigh the risks of side effects". (HANDLE).
Ema, recommendation on J&J next week
2021-04-14T14:01:59.731Z
The EMA makes it known in a note that "it is investigating all reported cases" regarding the Johnson & Johnson vaccine "and will decide whether regulatory action is necessary. (ANSA)
